$ORGO
Organogenesis Holdings Inc.

2021 Q2 Form 10-Q Financial Statement

#000119312521156534 Filed on May 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2021 Q1 2020 Q4
Revenue $123.2M $102.6M $106.8M
YoY Change 78.65% 66.12% 43.16%
Cost Of Revenue $29.94M $25.50M $25.50M
YoY Change 49.39% 35.66% 25.0%
Gross Profit $93.26M $77.06M $81.30M
YoY Change 90.64% 79.46% 49.72%
Gross Profit Margin 75.7% 75.14% 76.12%
Selling, General & Admin $62.35M $58.23M $53.20M
YoY Change 34.08% 10.68% 1.53%
% of Gross Profit 66.86% 75.57% 65.44%
Research & Development $7.320M $6.209M $6.300M
YoY Change 56.81% 14.77% 75.0%
% of Gross Profit 7.85% 8.06% 7.75%
Depreciation & Amortization $2.309M $1.010M $2.200M
YoY Change 159.15% 11.97% -6.38%
% of Gross Profit 2.48% 1.31% 2.71%
Operating Expenses $69.67M $64.44M $59.50M
YoY Change 36.15% 11.06% 6.25%
Operating Profit $23.59M $12.62M $21.80M
YoY Change -1147.38% -183.64% -1382.35%
Interest Expense -$2.431M $2.470M -$2.900M
YoY Change -183.48% -1.59% 11.54%
% of Operating Profit -10.31% 19.58% -13.3%
Other Income/Expense, Net $18.00K -$2.473M $0.00
YoY Change -100.62% 107.12%
Pretax Income $21.17M $10.14M $18.90M
YoY Change -512.03% -162.31% -529.55%
Income Tax $487.0K $200.0K $400.0K
% Of Pretax Income 2.3% 1.97% 2.12%
Net Earnings $20.69M $9.943M $18.50M
YoY Change -500.45% -160.95% -520.45%
Net Earnings / Revenue 16.79% 9.7% 17.32%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $154.4K $0.07 $141.0K
COMMON SHARES
Basic Shares Outstanding 128.2M 127.9M 107.8M
Diluted Shares Outstanding 133.5M

Balance Sheet

Concept 2021 Q2 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.79M $77.50M $84.40M
YoY Change 121.7% 65.25% 40.2%
Cash & Equivalents $77.96M $84.81M
Short-Term Investments
Other Short-Term Assets $7.100M $6.100M $5.300M
YoY Change 51.06% 12.96% 65.63%
Inventory $28.11M $29.72M $27.80M
Prepaid Expenses $5.557M $4.935M
Receivables $76.77M $72.00M $56.80M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $201.8M $185.2M $174.3M
YoY Change 71.41% 66.29% 38.81%
LONG-TERM ASSETS
Property, Plant & Equipment $96.27M $62.43M $60.07M
YoY Change 81.53% 24.68% 27.31%
Goodwill $28.77M $28.77M
YoY Change 12.66% 12.66%
Intangibles $29.38M $30.62M
YoY Change 47.03% 47.24%
Long-Term Investments
YoY Change
Other Assets $623.0K $636.0K $670.0K
YoY Change -14.42% -16.32% -24.21%
Total Long-Term Assets $153.8M $133.9M $120.2M
YoY Change 55.7% 38.17% 26.36%
TOTAL ASSETS
Total Short-Term Assets $201.8M $185.2M $174.3M
Total Long-Term Assets $153.8M $133.9M $120.2M
Total Assets $355.6M $319.2M $294.5M
YoY Change 64.24% 53.2% 33.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.79M $23.88M $23.38M
YoY Change -10.54% -8.89% -17.63%
Accrued Expenses $31.12M $25.38M $23.97M
YoY Change 26.06% 16.42% 2.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $26.63M $20.70M $20.30M
YoY Change 166.34% 322.45% 554.84%
Total Short-Term Liabilities $84.55M $74.01M $68.22M
YoY Change 27.99% 34.99% 13.9%
LONG-TERM LIABILITIES
Long-Term Debt $56.84M $63.40M $64.50M
YoY Change -46.02% -39.68% 29.95%
Other Long-Term Liabilities $35.25M $8.332M $7.971M
YoY Change 326.6% 19.61% 19.88%
Total Long-Term Liabilities $92.10M $8.332M $7.971M
YoY Change 1014.44% 19.61% -85.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $84.55M $74.01M $68.22M
Total Long-Term Liabilities $92.10M $8.332M $7.971M
Total Liabilities $176.6M $161.9M $148.4M
YoY Change -2.27% -3.66% -10.11%
SHAREHOLDERS EQUITY
Retained Earnings -$140.8M -$150.8M
YoY Change -24.83% -11.84%
Common Stock $298.1M $296.8M
YoY Change 30.97% 31.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $178.9M $157.3M $146.1M
YoY Change
Total Liabilities & Shareholders Equity $355.6M $319.2M $294.5M
YoY Change 64.24% 53.2% 33.44%

Cashflow Statement

Concept 2021 Q2 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income $20.69M $9.943M $18.50M
YoY Change -500.45% -160.95% -520.45%
Depreciation, Depletion And Amortization $2.309M $1.010M $2.200M
YoY Change 159.15% 11.97% -6.38%
Cash From Operating Activities $17.66M -$1.479M $26.28M
YoY Change -289.08% -91.44% -510.62%
INVESTING ACTIVITIES
Capital Expenditures -$4.330M $4.957M -$8.890M
YoY Change 99.54% 16.83% 157.68%
Acquisitions
YoY Change
Other Investing Activities -$180.0K $180.0K $400.0K
YoY Change -162.07%
Cash From Investing Activities -$4.510M -$4.778M -$8.480M
YoY Change 139.89% 12.61% 145.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -799.0K -591.0K 30.12M
YoY Change -116.34% -107.18% -36.01%
NET CHANGE
Cash From Operating Activities 17.66M -1.479M 26.28M
Cash From Investing Activities -4.510M -4.778M -8.480M
Cash From Financing Activities -799.0K -591.0K 30.12M
Net Change In Cash 12.35M -6.848M 47.92M
YoY Change -295.12% -48.5% 28.75%
FREE CASH FLOW
Cash From Operating Activities $17.66M -$1.479M $26.28M
Capital Expenditures -$4.330M $4.957M -$8.890M
Free Cash Flow $21.99M -$6.436M $35.17M
YoY Change -406.69% -70.1% -1292.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Cash
Cash
84394000
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
412000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5557000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4935000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
185239000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
174344000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30622000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29379000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18000
CY2021Q1 us-gaap Cash
Cash
77458000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
670000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
636000
CY2020Q4 us-gaap Assets
Assets
294494000
CY2021Q1 us-gaap Assets
Assets
319181000
CY2021Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
16875000
CY2020Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3619000
CY2020Q1 orgo Non Cash Interest Expense
NonCashInterestExpense
46000
CY2021Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3870000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23381000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23877000
CY2020Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
23973000
CY2021Q1 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
25383000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68217000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
74009000
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
10000000
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
10000000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7971000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8332000
CY2020Q4 us-gaap Liabilities
Liabilities
148410000
CY2021Q1 us-gaap Liabilities
Liabilities
161889000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
13000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
296830000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
298095000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150759000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140816000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
294494000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
319181000
CY2021Q1 us-gaap Revenues
Revenues
102552000
CY2020Q1 us-gaap Revenues
Revenues
61732000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
25495000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
18793000
CY2021Q1 us-gaap Gross Profit
GrossProfit
77057000
CY2020Q1 us-gaap Gross Profit
GrossProfit
42939000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58232000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52613000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6209000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5410000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
64441000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
58023000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12616000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15084000
CY2020Q1 us-gaap Interest Expense
InterestExpense
2510000
CY2021Q1 us-gaap Interest Expense
InterestExpense
2470000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1194000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2473000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10143000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16278000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
9943000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-16313000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9943000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-16313000
CY2021Q1 us-gaap Depreciation
Depreciation
1010000
CY2020Q1 us-gaap Depreciation
Depreciation
902000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-201000
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-239000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
209000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1243000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
817000
CY2021Q1 orgo Non Cash Interest Expense
NonCashInterestExpense
72000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2942000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
306000
CY2021Q1 orgo Working Capital
WorkingCapital
111230000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140816000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1479000
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
78079000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
61792000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6076000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4988000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72003000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56804000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4988000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1103000
CY2021Q1 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-15000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6076000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11436000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10075000
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
764000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
698000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6325000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16301000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4287000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4212000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2099000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
622000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1910000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1842000
CY2020Q1 orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-1274000
CY2021Q1 orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1411000
CY2020Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-153000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-164000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17283000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1479000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4243000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4957000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4243000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4778000
CY2021Q1 orgo Payments Of Deferred Acquisition Consideration
PaymentsOfDeferredAcquisitionConsideration
483000
CY2020Q1 orgo Payments Of Deferred Acquisition Consideration
PaymentsOfDeferredAcquisitionConsideration
2042000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8230000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-591000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13296000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6848000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60370000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84806000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47074000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77958000
CY2020Q1 us-gaap Interest Paid
InterestPaid
2244000
CY2021Q1 us-gaap Interest Paid
InterestPaid
1937000
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1305000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25383000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23973000
CY2021Q1 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
7171415
CY2020Q4 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
6425040
CY2021Q1 orgo Shares Reserved For Issuance For Future Grant
SharesReservedForIssuanceForFutureGrant
5578422
CY2020Q4 orgo Shares Reserved For Issuance For Future Grant
SharesReservedForIssuanceForFutureGrant
6832649
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13683051
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14063737
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
698000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69521000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62431000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60068000
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
46400000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
46400000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17021000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15778000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29379000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30622000
CY2021Q1 us-gaap Goodwill
Goodwill
28772000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20374000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18943000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2158000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2059000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17521000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
16419000
CY2021Q1 us-gaap Inventory Net
InventoryNet
29721000
CY2020Q4 us-gaap Inventory Net
InventoryNet
27799000
CY2021Q1 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
2290000
CY2020Q1 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
769000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88769000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87810000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70525000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
209000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.31
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
143000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
144000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0082
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M15D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3930
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
13.54
CY2021Q1 orgo Fair Value Of Common Share
FairValueOfCommonShare
13.54
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6620318
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5380
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
480622
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7171415
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4418977
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6588701
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.33
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.54
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.10
CY2021Q1 orgo Deferred Acquisition Consideration Noncurrrent
DeferredAcquisitionConsiderationNoncurrrent
1436000
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3689000
CY2020Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
43044000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4935000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
128102255
CY2021Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
42876000
CY2020Q4 orgo Prepaid Deposits
PrepaidDeposits
1438000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.04
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.96
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.64
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.54
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M19D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M3D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y6M
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
34458000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
102239000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4283000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
73271000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
96754000
CY2021Q1 orgo Accrued Legal Expenses
AccruedLegalExpenses
150000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
157292000
CY2021Q1 orgo Deferred Interest Expense
DeferredInterestExpense
525000
CY2020Q1 orgo Deferred Interest Expense
DeferredInterestExpense
470000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-296000
CY2021Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2851000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2971000
CY2021Q1 orgo Prepaid Subscription
PrepaidSubscription
2529000
CY2020Q4 orgo Prepaid Subscription
PrepaidSubscription
2013000
CY2021Q1 us-gaap Prepaid Advertising
PrepaidAdvertising
240000
CY2020Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
63000
CY2021Q1 orgo Prepaid Deposits
PrepaidDeposits
1586000
CY2021Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1202000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
412000
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5557000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3782000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127870065
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104486924
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133451950
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104486924
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1202193
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7169780
CY2021Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
179000
CY2021Q1 orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-2290000
CY2020Q1 orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-769000
CY2020Q4 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
5500000
CY2020Q4 orgo Employee Retention Benefitsnumberofemployees
EmployeeRetentionBenefitsnumberofemployees
70
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
11250000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
22500000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
22500000
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
13750000
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
70000000
CY2021Q1 orgo Sharesreservedforissuanceforoutstandingrestrictedstockunits
Sharesreservedforissuanceforoutstandingrestrictedstockunits
933214
CY2020Q4 orgo Deferred Acquisition Consideration Liability Current
DeferredAcquisitionConsiderationLiabilityCurrent
483000
CY2021Q1 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
179000
CY2020Q1 orgo Noncash Deferred Rent Expense And Lease Incentive Obligation
NoncashDeferredRentExpenseAndLeaseIncentiveObligation
92000
CY2021Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1545000
CY2020 orgo Reimbursement Of Offering Expenses Included In Prepaid Expenses And Other Current Assets
ReimbursementOfOfferingExpensesIncludedInPrepaidExpensesAndOtherCurrentAssets
1009000
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Organogenesis Holdings Inc.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001661181
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Trading Symbol
TradingSymbol
ORGO
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12706000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4004000
CY2020Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
16666000
CY2020Q4 orgo Deferred Acquisition Consideration Noncurrrent
DeferredAcquisitionConsiderationNoncurrrent
1436000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3985000
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-417000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
146084000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-984000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-698000
CY2020Q4 orgo Deferred Rent And Lease Incentive Obligation Noncurrent
DeferredRentAndLeaseIncentiveObligationNoncurrent
2315000
CY2021Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
10516000
CY2020Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
11442000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11031000
CY2020Q4 orgo Deferred Rent And Lease Incentive Obligation Current
DeferredRentAndLeaseIncentiveObligationCurrent
95000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128830803
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128460381
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127731833
CY2021Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
700000
CY2020Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
960000
CY2020Q1 orgo Gain Loss On Deferred Acquisition Consideration Settlement
GainLossOnDeferredAcquisitionConsiderationSettlement
1295000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55583000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-816000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-209000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
40295000
CY2020Q4 us-gaap Goodwill
Goodwill
28772000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3049000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
217000
CY2020Q1 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-62000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3204000
CY2020Q1 orgo Gain Loss On Deferred Acquisition Consideration Settlement
GainLossOnDeferredAcquisitionConsiderationSettlement
1295000
CY2021Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
1210000
CY2020Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
10000000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
417000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
984000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
816000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
675000
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
544000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
15935000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13525000
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
10000
CY2021Q1 orgo Other Working Capital Components
OtherWorkingCapitalComponents
33772000
CY2020Q4 orgo Accrued Legal Expenses
AccruedLegalExpenses
150000
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
1295000
CY2020Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
951000
CY2020Q4 orgo Sharesreservedforissuanceforoutstandingrestrictedstockunits
Sharesreservedforissuanceforoutstandingrestrictedstockunits
806048
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
299000
CY2021Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
349000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1280000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
715000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1363000
CY2021Q1 us-gaap Lease Cost
LeaseCost
4006000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
22989000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
15274000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
7715000
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3870000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10516000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
14386000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1037099
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1362000
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
523000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
675000
CY2021Q1 orgo Rightofuse Asset Obtained In Exchange For Operating Lease Liability Upon Adoption
RightofuseAssetObtainedInExchangeForOperatingLeaseLiabilityUponAdoption
13525000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
310000
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1958
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0398
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3785000
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
3588000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
2831000
CY2021Q1 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
4945000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
2159000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
1443000
CY2021Q1 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
9796000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
1383000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
5631000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17232000
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
18329000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2197000
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
3943000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
15035000
CY2020Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
22989000
CY2020Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
14974000
CY2020Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
15061000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1514000
CY2021Q1 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
0
CY2021Q1 us-gaap Finance Lease Liability Payments Due In Rolling Year Four
FinanceLeaseLiabilityPaymentsDueInRollingYearFour
0
CY2021Q1 us-gaap Finance Lease Liability Payments Due In Rolling After Year Five
FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive
0
CY2021Q1 orgo Finance Lease Cost
FinanceLeaseCost
648000
CY2021Q1 orgo Reimbursement Of Offering Expenses Included In Prepaid Expenses And Other Current Assets
ReimbursementOfOfferingExpensesIncludedInPrepaidExpensesAndOtherCurrentAssets
0
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M23D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M20D
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1129000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
22989000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
14974000
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
8015000
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3619000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
11442000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
15061000
CY2021Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
30000000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure as of the date of the consolidated financial statements and the reported results of operations during the reporting periods. Actual results could differ from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
128218266

Files In Submission

Name View Source Status
0001193125-21-156534-index-headers.html Edgar Link pending
0001193125-21-156534-index.html Edgar Link pending
0001193125-21-156534.txt Edgar Link pending
0001193125-21-156534-xbrl.zip Edgar Link pending
d143487d10q.htm Edgar Link pending
d143487dex102.htm Edgar Link pending
d143487dex103.htm Edgar Link pending
d143487dex104.htm Edgar Link pending
d143487dex311.htm Edgar Link pending
d143487dex312.htm Edgar Link pending
d143487dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
orgo-20210331.xml Edgar Link completed
orgo-20210331.xsd Edgar Link pending
orgo-20210331_cal.xml Edgar Link unprocessable
orgo-20210331_def.xml Edgar Link unprocessable
orgo-20210331_lab.xml Edgar Link unprocessable
orgo-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending